| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Original Research |
1 Department of Radiology, Duke University Medical Center, Box 3808, Durham, NC
27705.
2 Department of Biomedical Engineering, Duke University Medical Center, Durham,
NC 27710.
3 Department of Chemical Engineering, University of Houston, Houston, TX
77204.
4 Department of Biomedical Engineering, Georgia Institute of Technology/Emory
University, Atlanta, GA 30332.
5 Department of Bioinformatics, University of Texas, Health Science Center at
Houston, Houston, TX 77030.
OBJECTIVE. The goal of this study was to determine if an iodinated, liposomal contrast agent could be used for high-resolution, micro-CT of low-contrast, small-size vessels in a murine model.
MATERIALS AND METHODS. A second-generation, liposomal blood pool contrast agent encapsulating a high concentration of iodine (83–105 mg I/mL) was evaluated. A total of five mice weighing between 20 and 28 g were infused with equivalent volume doses (500 µL of contrast agent/25 g of mouse weight) and imaged with our micro-CT system for intervals of up to 240 min postinfusion. The animals were anesthetized, mechanically ventilated, and vital signs monitored allowing for simultaneous cardiac and respiratory gating of image acquisition.
RESULTS. Initial enhancement of about 900 H in the aorta was obtained, which decreased to a plateau level of approximately 800 H after 2 hr. Excellent contrast discrimination was shown between the myocardium and cardiac blood pool (650–700 H). No significant nephrogram was identified, indicating the absence of renal clearance of the agent.
CONCLUSION. The liposomal-based iodinated contrast agent shows long residence time in the blood pool, very high attenuation within submillimeter vessels, and no significant renal clearance rendering it an effective contrast agent for murine vascular imaging using a micro-CT scanner.
Keywords: animal studies • contrast media • CT • molecular imaging
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  D. P. Cormode, T. Skajaa, Z. A. Fayad, and W. J.M. Mulder Nanotechnology in Medical Imaging: Probe Design and Applications Arterioscler Thromb Vasc Biol, July 1, 2009; 29(7): 992 - 1000. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Karathanasis, S. Suryanarayanan, S. R. Balusu, K. McNeeley, I. Sechopoulos, A. Karellas, A. V. Annapragada, and R. V. Bellamkonda Imaging Nanoprobe for Prediction of Outcome of Nanoparticle Chemotherapy by Using Mammography Radiology, February 1, 2009; 250(2): 398 - 406. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Brown, C. G. Irvin, G. B. Allen III, S. D. Shapiro, W. J. Martin, M. R. J. Kolb, D. M. Hyde, G. F. Nieman, D. D. Cody, M. Ishii, et al. An Official ATS Conference Proceedings: Advances in Small-Animal Imaging Application to Lung Pathophysiology Proceedings of the ATS, July 15, 2008; 5(5): 591 - 600. [Full Text] [PDF]
|
|
|
|
 |
|
 K.B. Ghaghada, K.H.J. Bockhorst, S. Mukundan Jr, A.V. Annapragada, and P.A. Narayana High-Resolution Vascular Imaging of the Rat Spine Using Liposomal Blood Pool MR Agent AJNR Am. J. Neuroradiol., January 1, 2007; 28(1): 48 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Provenzale Molecular Imaging: Facing the Future Am. J. Roentgenol., February 1, 2006; 186(2): 287 - 288. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
